MRI Evaluates Angiogenesis

Health Imaging News reported on Perceptive Informatics’s improved technique to monitor tumors with technology based on magnetic resonance imaging. The new imaging tool more closely examines the blood flow of tumors, which is a critical component of tumor activity.

The new technology, dubbed the Double Reference Tissue Method (DRTM) is based on MRI technology. The benefit of the tool is the ability to monitor tumor activity during treatment.

A continued area of therapeutic research for solid malignancies is anti-angiogenic agents. This imaging method may offer superior results to monitor the effects of these treatments.

Related stories:

May 31, 2007 Related topics: Imaging, Radiology, Hematology & Oncology

Today on
Hospital Buyer

HospitalBuyer Undergoing Surgery

HospitalBuyer is on long-term hiatus. We may come back in new and improved form in the future, but...

CT Scans Alter ER Decision-Making About Appendicitis

Data collected from CT scanning of the abdomen and pelvis can alter decision-making by clinicians regarding those patients...

MediNotes Purchase Completed by Eclipsys

Eclipsys Corporation announced that the acquisition (pdf) of MediNotes was finalized. MediNotes is now a wholly owned subsidiary...
http://www.hospitalbuyer.com